Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spiriva
Pharma
Theravance's COPD med Yupelri flunks head-to-head study
Theravance and Viatris’ Yupelri failed to demonstrate greater lung function improvement in adults with COPD versus Boehringer's Spiriva.
Fraiser Kansteiner
Jan 5, 2024 10:14am
Lupin scores FDA nod for first generic version of BI's Spiriva
Jun 22, 2023 8:00am
Boehringer Ingelheim opens inhaler plant with 200 jobs
Jun 17, 2019 10:29am
BI expands adherence-improving respiratory rewards program
Apr 23, 2018 9:20am
Asthma’s a real bear in new Boehringer TV campaign for Spiriva
Oct 3, 2017 8:47am
Can gift cards spur Boehringer COPD patients to stick to meds?
Jun 12, 2016 1:14pm
